Results 91 to 100 of about 5,025 (229)

DNA repair modulates the vulnerability of the developing brain to alkylating agents [PDF]

, 2008
Neurons of the developing brain are especially vulnerable to environmental agents that damage DNA (i.e., genotoxicants), but the mechanism is poorly understood.
A. Olivas, Ahles, Allan, Bobola, Brewer, Briegert, Butler, Cai, Churchwell, D. Doerge, De Alencar, Dumenco, Eizirik, Engelward, Everson, Friedberg, G.E. Kisby, Gerson, Glassner, Gleeson, Gonzaga, Harrison, Humphreys, Kagami, Kaina, Kisby, Kisby, Kisby, Kisby, Kleihues, L.D. Samson, Larsen, Lawley, Loeber, Ludlum, Lyras, M. Churchwell, M.S. Turker, Maor-Shoshani, Matijasevic, Matsumoto, Matsumoto, McHugh, McHugh, Mecocci, Mecocci, Meira, Moller, Mulhern, Nishioka, Passagne, Perera, Perera, Perera, Povirk, Rinne, Roth, S.L. Gerson, Sarkar, Sedgwick, Silber, Springer, T. Park, Tang, Tokuda, Valadez, Wang, White, Wijen, Wong, Wu   +70 more
core   +1 more source

Successful treatment of lymphomatoid papulosis with chlormethine gel

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 6, Page 826-827, June 2024.
Tassilo Dege, Isabel Netzer, Katharina Strobel, Matthias Goebeler, Marion Wobser   +4 more
wiley   +1 more source

Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.

JAMA dermatology, 2013
OBJECTIVE To evaluate the efficacy and safety of a novel mechlorethamine hydrochloride, 0.02%, gel in mycosis fungoides. DESIGN Randomized, controlled, observer-blinded, multicenter trial comparing mechlorethamine, 0.02%, gel with mechlorethamine, 0.02%,
S. Lessin, M. Duvic, J. Guitart, A. Pandya, B. Strober, E. Olsen, C. Hull, E. Knobler, A. Rook, Ellen J. Kim, M. Naylor, D. Adelson, A. Kimball, G. Wood, U. Sundram, Hong-cheng Wu, Youn H. Kim   +16 more
semanticscholar   +1 more source

Large cell anaplastic lypmhoma versus Hodgkin's disease – difficulties in the diagnosis [PDF]

, 1998
During the last 5 years in the Polish Children's Leukemia/Lymphoma Study Group (7 centers) 241 children with Hodgkin's Disease and 14 children with Large Cell Anaplastic Lymphoma were treated.In 5 of them we had problems with differential diagnosis ...
Kaczmarek-Kanold, M., Kołecki, P., Sopyło, B., Stańczak, E., Stefańska, K., Trejster, E., Wróbel, G.   +6 more
core   +1 more source

Erfolgreiche Behandlung einer lymphomatoiden Papulose mit Chlormethin‐Gel

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 6, Page 826-828, June 2024.
Tassilo Dege, Isabel Netzer, Katharina Strobel, Matthias Goebeler, Marion Wobser   +4 more
wiley   +1 more source

Reduced intensity treatment in early-stage Hodgkin’s lymphoma

Blood and Lymphatic Cancer: Targets and Therapy, 2011
Prathima Prodduturi, James O ArmitageUniversity of Nebraska Medical Center, Omaha, NE, USAAbstract: Early-stage Hodgkin’s lymphoma which includes patients with Ann Arbor stages I or II, accounts for more than 50% of all cases of the illness and
Armitage JO, Prodduturi P
doaj  

CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) [PDF]

, 1996
Purpose. To test the adequacy of the CVPP four-drug regimen as ancillary chemotherapy associated with extended-field radiotherapy in the treatment of early, unfavorable, clinically staged Hodgkin's disease. Patients and Methods.
Angrilli, F, Callea, V, Carotenuto, M, Cavanna, L, Corbella, F, Federico, Massimo, Formisano, R, Gobbi, Pg, Merli, F, Pieresca, C, Silingardi, Vittorio, Vallisa, D   +11 more
core  

Treatment of lower torso stages I and Ii Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone [PDF]

, 1990
Stanley S. Givens, Lillian M. Fuller, Fredrick B. Hagemeister, Edmund A. Gehan   +3 more
openalex   +1 more source

CINV Survey [PDF]

, 2016
Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of chemotherapeutic treatment experienced by dogs that can lower quality of life and functionality.
Hackbarth, Lauren
core   +1 more source

The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine [PDF]

, 2000
John P.H. Wijen
openalex   +1 more source